{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T03:56:31Z","timestamp":1784606191095,"version":"3.55.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>CXC chemokine receptor type 4 as a G-protein\u2013coupled receptor has been confirmed to be highly expressed in functional adrenocortical adenomas. <jats:sup>68<\/jats:sup>Ga-pentixafor, a CXC chemokine receptor type 4\u2013specific ligand, has been reported as a promising tracer to evaluate functional nature of adrenal adenomas. We report intense <jats:sup>68<\/jats:sup>Ga-pentixafor activity of cortisol-producing adrenal adenomas in 2 patients with adrenocorticotropic hormone\u2013independent Cushing syndrome.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003503","type":"journal-article","created":{"date-parts":[[2021,1,25]],"date-time":"2021-01-25T01:00:20Z","timestamp":1611536420000},"page":"350-352","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":10,"title":["Cortisol-Producing Adrenal Adenomas With Intense Activity on 68Ga-Pentixafor PET\/CT"],"prefix":"10.1097","volume":"46","author":[{"given":"Jie","family":"Ding","sequence":"first","affiliation":[{"name":"Department of Nuclear Medicine and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anli","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Key Laboratory of Endocrinology, Ministry of Health, and Departments of"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YuShi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Urology"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[{"name":"Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Huo","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,28]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1007\/s00259-020-04722-0","article-title":"Imaging CXCR4 expression in patients with suspected primary hyperaldosteronism","volume":"47","year":"2020","journal-title":"Eur J Nucl Med Mol Imag"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2214\/AJR.16.17290","article-title":"Cushing syndrome: diagnostic workup and imaging features, with clinical and pathologic correlation","volume":"209","year":"2017","journal-title":"AJR Am J Roentgenol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME position statement on adrenal incidentaloma","volume":"164","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nrendo.2011.92","article-title":"Endocrine incidentalomas\u2014challenges imposed by incidentally discovered lesions","volume":"7","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/HYPERTENSIONAHA.117.09975","article-title":"Targeting CXCR4 (CXC chemokine receptor type 4) for molecular imaging of aldosterone-producing adenoma","volume":"71","year":"2018","journal-title":"Hypertension"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1097\/RLU.0000000000002946","article-title":"Intense 68Ga-pentixafor activity in aldosterone-producing adrenal adenomas","volume":"45","year":"2020","journal-title":"Clin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1186\/1756-0500-5-602","article-title":"Primary hyperaldosteronism: challenges in subtype classification","volume":"5","year":"2012","journal-title":"BMC Res Notes"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003503","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T21:04:46Z","timestamp":1750539886000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,28]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003503","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,28]]}}}